Structure of NLG802, a prodrug of indoximod

oral prodrug of IDO1 inhibitor

completed Ph. I in solid tumors

from derivatization of indoximod

Eur. J. Med. Chem., May 1, 2020

NewLink Genetics, Ames, IA

NLG802 is a prodrug of the IDO1 inhibitor indoximod with significantly enhanced oral exposure. Both the acid and amine functionalities of indoximod are protected as an ethyl ester and…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.